This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1995 Jun;162(6):548-51.

Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda

A C Liu¹

Affiliations

PMID: 7618323
PMCID: PMC1022841

Case Reports

Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda

A C Liu. West J Med. 1995 Jun.

. 1995 Jun;162(6):548-51.

Author

A C Liu¹

Affiliation

¹ Palo Alto Medical Foundation, CA 94022, USA.

PMID: 7618323
PMCID: PMC1022841

No abstract available

PubMed Disclaimer

Similar articles

Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment.
Rossmann-Ringdahl I, Olsson R. Rossmann-Ringdahl I, et al. Acta Derm Venereol. 2007;87(5):401-5. doi: 10.2340/00015555-0260. Acta Derm Venereol. 2007. PMID: 17721646
Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Calvert GM, Sweeney MH, Fingerhut MA, Hornung RW, Halperin WE. Calvert GM, et al. Am J Ind Med. 1994 Apr;25(4):559-71. doi: 10.1002/ajim.4700250410. Am J Ind Med. 1994. PMID: 7912041 Review.
Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
To-Figueras J, Ozalla D, Mateu CH. To-Figueras J, et al. Ann Clin Lab Sci. 2003 Summer;33(3):251-6. Ann Clin Lab Sci. 2003. PMID: 12956438
[Case no. 5. Bullous dermatosis].
Battistella M. Battistella M. Ann Pathol. 2013 Jun;33(3):196-201. doi: 10.1016/j.annpat.2013.04.013. Epub 2013 May 27. Ann Pathol. 2013. PMID: 23790661 Review. French. No abstract available.
[Effect of chloroquine in porphyria cutanea tarda].
Herrero C, Muniesa A. Herrero C, et al. Med Cutan Ibero Lat Am. 1980;8(4-6):139-45. Med Cutan Ibero Lat Am. 1980. PMID: 7024672 Spanish.

See all similar articles

Cited by

Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats.
Niknahad H, Heidari R, Firuzi R, Abazari F, Ramezani M, Azarpira N, Hosseinzadeh M, Najibi A, Saeedi A. Niknahad H, et al. Adv Pharm Bull. 2016 Dec;6(4):617-625. doi: 10.15171/apb.2016.076. Epub 2016 Dec 22. Adv Pharm Bull. 2016. PMID: 28101469 Free PMC article.
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Marin S, Martin Val A, Bosch Peligero M, Rodríguez-Bernuz C, Pérez-Ricart A, Vilaró Jaques L, Paredes R, Roca J, Quiñones C. Marin S, et al. Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634. Pharmaceuticals (Basel). 2022. PMID: 35631460 Free PMC article. Review.
Protective effect of quercetin on chloroquine-induced oxidative stress and hepatotoxicity in mice.
Kumar Mishra S, Singh P, Rath SK. Kumar Mishra S, et al. Malar Res Treat. 2013;2013:141734. doi: 10.1155/2013/141734. Epub 2013 Mar 27. Malar Res Treat. 2013. PMID: 23607047 Free PMC article.

References

1. Arch Dermatol. 1986 Apr;122(4):403-4 - PubMed
1. Semin Dermatol. 1990 Mar;9(1):63-9 - PubMed
1. J Invest Dermatol. 1973 Oct;61(4):226-32 - PubMed
1. Hepatology. 1992 Dec;16(6):1322-6 - PubMed
1. JAMA. 1977 Jun 20;237(25):2753-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central